|
Volumn 51, Issue 6-9, 1996, Pages 91-93
|
Tissue type plasminogen activator and its inhibition in blood of patients operated on for prostatic carcinoma;Tkankowy aktywator plazminogenu i jego inhibitor we krwi chorych operowanych z powodu raka gruczołu krokowego.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIPLASMIN;
FIBRIN DEGRADATION PRODUCT;
PLASMIN;
PLASMINOGEN;
PLASMINOGEN ACTIVATOR;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
SERINE PROTEINASE INHIBITOR;
TISSUE PLASMINOGEN ACTIVATOR;
AGED;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FIBRINOLYSIS;
HUMAN;
MALE;
METABOLISM;
MIDDLE AGED;
PHYSIOLOGY;
PROSTATE TUMOR;
AGED;
AGED, 80 AND OVER;
ANTIPLASMIN;
FIBRIN FIBRINOGEN DEGRADATION PRODUCTS;
FIBRINOLYSIS;
HUMANS;
MALE;
MIDDLE AGED;
PLASMIN;
PLASMINOGEN;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
PLASMINOGEN ACTIVATORS;
PROSTATIC NEOPLASMS;
SERINE PROTEINASE INHIBITORS;
TISSUE PLASMINOGEN ACTIVATOR;
|
EID: 0030075664
PISSN: 00323756
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|